Serum and Urine Neutrophil Gelatinase-Associated Lipocalin Levels Measured at Admission Predict Progression to Chronic Kidney Disease in Sepsis-Associated Acute Kidney Injury Patients

Pham Ngoc Huy Tuan, Dao Bui Quy Quyen, Huynh Van Khoa, Nguyen Duc Loc, Pham Van My, Nguyễn Hữu Dũng, Nguyen Duy Toan, Quyết Đỗ, Thắng Lê Việt

Disease Markers · 2020 · 13 citations · 26 references

DOIFull text

Open access

Concepts

Abstract

Background . To evaluate the ratio of acute kidney injury (AKI) to chronic kidney disease (CKD) in sepsis-associated acute kidney injury (SA-AKI) patients of the intensive care unit (ICU) and predictive value of neutrophil gelatinase-associated lipocalin (NGAL) measured at the admission time in the progression of AKI to CKD. Methods . A study of 121 consecutive adult patients admitted to the intensive care unit (ICU) diagnosed as SA-AKI. AKI and CKD were defined based on Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Glomerular filtration rate (GFR) was calculated by the CKD-EPI formula. Serum and urine NGAL was measured using the BioVendor Human Lipocalin-2/NGAL ELISA with a blood sample taken at hospital admission time. Results . The ratio of AKI to CKD in SA-AKI patients was 22.3%. Mean concentration of serum and urine NGAL in AKI to the CKD group was 790.99 ng/ml and 885.72 ng/ml, higher significantly than those of recovery patients (351.86 ng/ml and 264.68 ng/ml), <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.001</mml:mn></mml:math>. eGFR, both serum and urine NGAL had a predictive value for AKI to CKD (eGFR: <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mtext>AUC</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.857</mml:mn></mml:math>, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mtext>Se</mml:mtext><mml:mo>=</mml:mo><mml:mn>74.1</mml:mn><mml:mi>%</mml:mi></mml:math>, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mtext>Spe</mml:mtext><mml:mo>=</mml:mo><mml:mn>92.6</mml:mn><mml:mi>%</mml:mi></mml:math>, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.001</mml:mn></mml:math>. Serum NGAL: <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mtext>AUC</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.868</mml:mn></mml:math>, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mtext>Se</mml:mtext><mml:mo>=</mml:mo><mml:mn>77.8</mml:mn><mml:mi>%</mml:mi></mml:math>, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mtext>Spe</mml:mtext><mml:mo>=</mml:mo><mml:mn>91.5</mml:mn><mml:mi>%</mml:mi></mml:math>. Urine NGAL: <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mtext>AUC</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.869</mml:mn></mml:math>, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mtext>Se</mml:mtext><mml:mo>=</mml:mo><mml:mn>77.8</mml:mn><mml:mi>%</mml:mi></mml:math>, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11"><mml:mtext>Spe</mml:mtext><mml:mo>=</mml:mo><mml:mn>92.6</mml:mn><mml:mi>%</mml:mi></mml:math>, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M12"><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.001</mml:mn></mml:math>. Conclusion . Serum and urine NGAL, measuring at hospital admission time, were good prognostic biomarkers of AKI to CKD in SA-AKI patients.

References

26